Victory Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Buy |
58,964
+5,647
| +11% | +$156K | ﹤0.01% | 1650 |
|
|
2025
Q1 | $1.18M | Buy |
+53,317
| New | +$1.18M | ﹤0.01% | 1730 |
|
|
2024
Q4 | – | Sell |
-14,902
| Closed | -$372K | – | 2505 |
|
|
2024
Q3 | $372K | Sell |
14,902
-2,441
| -14% | -$61K | ﹤0.01% | 2086 |
|
|
2024
Q2 | $324K | Buy |
17,343
+202
| +1% | +$3.77K | ﹤0.01% | 2081 |
|
|
2024
Q1 | $338K | Buy |
17,141
+2,488
| +17% | +$49.1K | ﹤0.01% | 2086 |
|
|
2023
Q4 | $257K | Buy |
14,653
+4,547
| +45% | +$79.8K | ﹤0.01% | 2169 |
|
|
2023
Q3 | $176K | Buy |
+10,106
| New | +$176K | ﹤0.01% | 2223 |
|
|
2023
Q1 | – | Sell |
-65,900
| Closed | -$987K | – | 2644 |
|
|
2022
Q4 | $987K | Buy |
65,900
+14,860
| +29% | +$223K | ﹤0.01% | 1745 |
|
|
2022
Q3 | $655K | Buy |
+51,040
| New | +$655K | ﹤0.01% | 1927 |
|
|
2020
Q2 | – | Sell |
-3,080
| Closed | -$48K | – | 2894 |
|
|
2020
Q1 | $48K | Buy |
+3,080
| New | +$48K | ﹤0.01% | 2781 |
|
|
2019
Q4 | – | Sell |
-236,905
| Closed | -$2.02M | – | 2956 |
|
|
2019
Q3 | $2.02M | Buy |
236,905
+158,776
| +203% | +$1.35M | ﹤0.01% | 1461 |
|
|
2019
Q2 | $1.06M | Sell |
78,129
-6,671
| -8% | -$90.3K | ﹤0.01% | 1290 |
|
|
2019
Q1 | $1.53M | Sell |
84,800
-940
| -1% | -$17K | ﹤0.01% | 1146 |
|
|
2018
Q4 | $2.41M | Sell |
85,740
-48,740
| -36% | -$1.37M | 0.01% | 992 |
|
|
2018
Q3 | $3.43M | Sell |
134,480
-7,390
| -5% | -$188K | 0.01% | 977 |
|
|
2018
Q2 | $2.46M | Buy |
+141,870
| New | +$2.46M | 0.01% | 1034 |
|